Literature DB >> 18663567

Epstein-Barr virus genetic variation in Vietnamese patients with nasopharyngeal carcinoma: full-length analysis of LMP1.

Do Nguyen-Van1, Ingemar Ernberg, Ingemar Enrberg, Phi Phan-Thi Phi, Chinh Tran-Thi, LiFu Hu.   

Abstract

Genetic variation in tumor virus genes and its impact on function might contribute to the understanding of geographic differences in risks for virus-associated tumors. This is particularly true for the genes known to contribute to the biology of the tumor. It is has been proposed that Epstein-Barr virus (EBV) gene variation has a role in the high risk of nasopharyngeal carcinoma (NPC) in South-East Asia. NPC is among the five most common cancers in Vietnam. EBV-NPC cells always express EBV nuclear antigen 1 (EBNA1) and also frequently latent membrane protein 1 and 2 (LMP1 & LMP2). To investigate EBV gene variation in Vietnamese NPC patients we analyzed the full length of LMP1 gene including its promoter region, and the N-termini of both EBNA1 and LMP2A genes from five NPC biopsies. We detected two EBV variants V1 and V2 based on the LMP1 nucleotide sequence pattern compared with the prototype B95-8 and some available sequences including Chinese variants. The V1 variant shows strong similarity to a variant dominant in Southern China (China 1), while the V2 variant is similar to a Thai variant SEA 2 and partly identity with GD1 in the C-terminus. The promoter region and transmembrane domain of the SEA 2-like samples contained some specific differences compared with previously published variants. In contrast, analysis of EBNA1 N- and LMP2A N-termini only revealed minor changes. Our findings reinforces that the polymorphisms of whole LMP1 sequence should be considered in future EBV molecular epidemiology studies in different geographic populations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18663567     DOI: 10.1007/s11262-008-0262-9

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  54 in total

Review 1.  Cellular signaling pathways engaged by the Epstein-Barr virus transforming protein LMP1.

Authors:  Eudoxia Hatzivassiliou; George Mosialos
Journal:  Front Biosci       Date:  2002-01-01

2.  [LMP1 gene variants of Epstein-Barr virus in patients with some lymphoproliferative malignancies].

Authors:  V E Gurtsevich; E V Goncharova; L N Shcherbak; A M Kovrigina; N A Falaleeva; L S Iakovleva; V N Stepina; A A Popova; A A Sterlikova; E A Osmanov; O A Pavlish
Journal:  Vopr Virusol       Date:  2006 Mar-Apr

3.  Analysis of LMP1 variants of EBV in Southern Thailand: evidence for strain-associated T-cell tropism and pathogenicity.

Authors:  Vannarat Saechan; Atsumi Mori; Winyou Mitarnun; Wannapa Settheetham-Ishida; Takafumi Ishida
Journal:  J Clin Virol       Date:  2006-04-17       Impact factor: 3.168

4.  A major EBNA1 variant from Asian EBV isolates shows enhanced transcriptional activity compared to prototype B95.8.

Authors:  Nguyen-Van Do; Ernberg Ingemar; Phan-Thi Phi Phi; Almqvist Jenny; Tran-Thi Chinh; Yixin Zeng; Lifu Hu
Journal:  Virus Res       Date:  2007-12-21       Impact factor: 3.303

5.  Natural 30 base pair and 69 base pair deletion variants of the LMP1 oncogene do stimulate NF-kappaB-mediated transcription.

Authors:  S Rothenberger; E Bachmann; C Berger; C McQuain; B F Odermatt; H Knecht
Journal:  Oncogene       Date:  1997-05-01       Impact factor: 9.867

6.  Variation in the sequence of Epstein Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt's lymphomas.

Authors:  K Bhatia; A Raj; M I Guitierrez; J G Judde; G Spangler; H Venkatesh; I T Magrath
Journal:  Oncogene       Date:  1996-07-04       Impact factor: 9.867

7.  Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes.

Authors:  J Sample; L Young; B Martin; T Chatman; E Kieff; A Rickinson; E Kieff
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

8.  Epidemiology of nasopharyngeal and salivary gland carcinoma in Greenland.

Authors:  H Albeck; N H Nielsen; H E Hansen; J Bentzen; H H Ockelmann; P Bretlau; H S Hansen
Journal:  Arctic Med Res       Date:  1992-10

9.  Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: high frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas.

Authors:  K Sandvej; S C Peh; B S Andresen; G Pallesen
Journal:  Blood       Date:  1994-12-15       Impact factor: 22.113

10.  Alterations in the structure of the EBV nuclear antigen, EBNA1, in epithelial cell tumours.

Authors:  D K Snudden; P R Smith; D Lai; M H Ng; B E Griffin
Journal:  Oncogene       Date:  1995-04-20       Impact factor: 9.867

View more
  14 in total

1.  Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens.

Authors:  Chaofeng Tu; Zhaoyang Zeng; Peng Qi; Xiayu Li; Zhengyuan Yu; Can Guo; Fang Xiong; Bo Xiang; Ming Zhou; Zhaojian Gong; Qianjin Liao; Jianjun Yu; Yi He; Wenling Zhang; Xiaoling Li; Yong Li; Guiyuan Li; Wei Xiong
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

2.  Genomic diversity of Epstein-Barr virus genomes isolated from primary nasopharyngeal carcinoma biopsy samples.

Authors:  H Kwok; C W Wu; A L Palser; P Kellam; P C Sham; D L W Kwong; A K S Chiang
Journal:  J Virol       Date:  2014-07-02       Impact factor: 5.103

3.  Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly expresses EBNA3A with conserved CD8 T-cell epitopes.

Authors:  Do Nguyen-Van; Colm Keane; Erica Han; Kimberley Jones; Jamie P Nourse; Frank Vari; Nathan Ross; Pauline Crooks; Olivier Ramuz; Michael Green; Lyn Griffith; Ralf Trappe; Andrew Grigg; Peter Mollee; Maher K Gandhi
Journal:  Am J Blood Res       Date:  2011-09-09

Review 4.  The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal.

Authors:  Cindy M Chang; Kelly J Yu; Sam M Mbulaiteye; Allan Hildesheim; Kishor Bhatia
Journal:  Virus Res       Date:  2009-07-23       Impact factor: 3.303

5.  Genetic diversity of EBV-encoded LMP1 in the Swiss HIV Cohort Study and implication for NF-Κb activation.

Authors:  Emilie Zuercher; Christophe Butticaz; Josiane Wyniger; Raquel Martinez; Manuel Battegay; Emmanuelle Boffi El Amari; Thanh Dang; Jean-François Egger; Jan Fehr; Esther Mueller-Garamvögyi; Andrea Parini; Stephan C Schaefer; Franziska Schoeni-Affolter; Christine Thurnheer; Marianne Tinguely; Amalio Telenti; Sylvia Rothenberger
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

6.  Genomic sequencing and comparative analysis of Epstein-Barr virus genome isolated from primary nasopharyngeal carcinoma biopsy.

Authors:  Hin Kwok; Amy H Y Tong; Chi Ho Lin; Si Lok; Paul J Farrell; Dora L W Kwong; Alan K S Chiang
Journal:  PLoS One       Date:  2012-05-10       Impact factor: 3.240

Review 7.  Epstein-barr virus sequence variation-biology and disease.

Authors:  Stelios Tzellos; Paul J Farrell
Journal:  Pathogens       Date:  2012-11-08

8.  Commentary: mechanistic considerations for associations between formaldehyde exposure and nasopharyngeal carcinoma.

Authors:  Chad M Thompson; Roland C Grafström
Journal:  Environ Health       Date:  2009-11-25       Impact factor: 5.984

9.  Detection of nasopharyngeal carcinoma in Morocco (North Africa) using a multiplex methylation-specific PCR biomarker assay.

Authors:  Imran Nawaz; Khalid Moumad; Debora Martorelli; Moulay Mustapha Ennaji; Xiaoying Zhou; Zhe Zhang; Riccardo Dolcetti; Meriem Khyatti; Ingemar Ernberg; Li-Fu Hu
Journal:  Clin Epigenetics       Date:  2015-08-22       Impact factor: 6.551

10.  Identification and Characterization of Epstein-Barr Virus Genomes in Lung Carcinoma Biopsy Samples by Next-Generation Sequencing Technology.

Authors:  Shanshan Wang; Hongchao Xiong; Shi Yan; Nan Wu; Zheming Lu
Journal:  Sci Rep       Date:  2016-05-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.